Literature DB >> 7586676

Dengue virus-induced human cytotoxic factor: production by peripheral blood leucocytes in vitro.

R Mukerjee1, U C Chaturvedi, R Dhawan.   

Abstract

During dengue type 2 virus (DV) infection of mice a unique cytokine, the cytotoxic factor (CF), is produced which reproduces the pathological lesions seen in patients of dengue haemorrhagic fever (DHF). Recently we have observed a CF-like protein in the sera of DHF cases. The present study was undertaken to investigate whether DV can stimulate human peripheral blood mononuclear cells (PBMC) in vitro to produce human CF (hCF). Cultures prepared from PBMC or its enriched subpopulations were inoculated with 1000 LD50 of DV and controls with normal mouse brain suspension (NMB). Aliquots of cultures were harvested daily from 24 h to 96 h and their supernatant (CS) and cells were separated. CS were screened for viral titres and for the presence of hCF by cytotoxicity assay, inhibition ELISA, dot blot and Western blot tests using anti-mouse-CF antibodies. The RNA from the cells was screened in Northern blot and dot blot tests for the presence of mRNA for CF. It was observed that hCF appeared in the CS of DV-infected culture of PBMC and T-enriched cells at 48 h and was present until 96 h; no CF was detected in CS of B cells or monocyte cultures. The production of hCF was abrogated by pretreatment of the T cells with anti-CD4 antibodies but not with anti-CD8 antibodies, indicating that hCF was produced by CD4+ T cells. The Northern blot analysis using oligonucleotide probes prepared on the basis of amino-terminal sequence of mouse CF, showed presence of mRNA for hCF in PBMC and T cell cultures. DV replicated in PBMC cultures with peak titres at 48 h. The findings of the present study demonstrate that DV-induced hCF is produced by human T cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7586676      PMCID: PMC1553409          DOI: 10.1111/j.1365-2249.1995.tb03775.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  17 in total

1.  Enzyme immunoassays in diagnostic medicine. Theory and practice.

Authors:  A Voller; D E Bidwell; A Bartlett
Journal:  Bull World Health Organ       Date:  1976       Impact factor: 9.408

2.  Purification and amino-terminal sequence of the dengue virus-induced cytotoxic factor.

Authors:  M Khanna; U C Chaturvedi
Journal:  Int J Exp Pathol       Date:  1992-02       Impact factor: 1.925

3.  Breakdown of the blood-brain barrier during dengue virus infection of mice.

Authors:  U C Chaturvedi; R Dhawan; M Khanna; A Mathur
Journal:  J Gen Virol       Date:  1991-04       Impact factor: 3.891

4.  Inhibition of the presentation of dengue virus antigen by macrophages to B cells by serine-protease inhibitors.

Authors:  N Rizvi; U C Chaturvedi; A Mathur
Journal:  Int J Exp Pathol       Date:  1991-02       Impact factor: 1.925

5.  Obligatory role of macrophages in dengue virus antigen presentation to B lymphocytes.

Authors:  N Rizvi; U C Chaturvedi; A Mathur
Journal:  Immunology       Date:  1989-05       Impact factor: 7.397

6.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

7.  Separation of T and B lymphocytes by nylon wool columns: evaluation of efficacy by functional assays in vivo.

Authors:  D Trizio; G Cudkowicz
Journal:  J Immunol       Date:  1974-10       Impact factor: 5.422

8.  Effect of immunosuppression on dengue virus infection in mice.

Authors:  U C Chaturvedi; P Tandon; A Mathur
Journal:  J Gen Virol       Date:  1977-09       Impact factor: 3.891

9.  Active immunization by a dengue virus-induced cytokine.

Authors:  U C Chaturvedi; R Mukerjee; R Dhawan
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

10.  Increased levels of interferon-gamma (IFN-gamma), IL-4 and transforming growth factor-beta (TGF-beta) mRNA expressing blood mononuclear cells in human HIV infection.

Authors:  V Navikas; J Link; B Wahren; C Persson; H Link
Journal:  Clin Exp Immunol       Date:  1994-04       Impact factor: 4.330

View more
  3 in total

1.  Dengue: A Clinicohaematological Profile.

Authors:  M Banerjee; T Chatterjee; G S Choudhary; V Srinivas; V K Kataria
Journal:  Med J Armed Forces India       Date:  2011-07-21

2.  Production of cytotoxic factor by peripheral blood mononuclear cells (PBMC) in patients with dengue haemorrhagic fever.

Authors:  R Agarwal; U C Chaturvedi; A Misra; R Mukerjee; S Kapoor; R Nagar; R Tandon; A Mathur
Journal:  Clin Exp Immunol       Date:  1998-06       Impact factor: 4.330

3.  Effect of adjuvants on immunization with dengue virus-induced cytotoxic factor.

Authors:  R Mukerjee; U C Chaturvedi
Journal:  Clin Exp Immunol       Date:  1995-12       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.